Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review

Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH112072FSA
  • |
  • Pages: 55
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Spectrum Pharmaceuticals Inc (SPPI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company's marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection); Zevalin (ibritumomab tiuxetan); Marqibo (vincristine sulfate liposome injection), Beleodaq (belinostat) and Evomela (Captisol-Enabled Melphalan). It also has drugs in mid-to-late stage development, namely, Rolontis (eflapegrastim) for chemotherapy-induced neutropenia; Qapzola (apaziquone) for Intravesical Instillation; and Poziotinib for the treatment of various types of cancers. The company markets its products through direct sales force in the US and through distributors in Europe. Spectrum is headquartered in Henderson, Nevada, the US.

Spectrum Pharmaceuticals Inc Key Recent Developments

Sep 24,2018: SPI Energy Co., Ltd. Exhibits its USolar Platform at Solar Power International 2018

Sep 24,2018: Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients

Sep 12,2018: Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial Into First-Line Therapy and Doses First Patient[TOPC : Pharma-Spectrum Pharmaceuticals Inc]

Sep 12,2018: Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial Into First-Line Therapy and Doses First Patient[TOPC : Pharma-Spectrum Pharmaceuticals Inc]

Aug 09,2018: Spectrum Pharmaceuticals reports second quarter 2018 financial results and pipeline update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Spectrum Pharmaceuticals Inc-Key Facts 6

Spectrum Pharmaceuticals Inc-Key Employees 7

Spectrum Pharmaceuticals Inc-Key Employee Biographies 8

Spectrum Pharmaceuticals Inc-Major Products and Services 9

Spectrum Pharmaceuticals Inc-History 10

Spectrum Pharmaceuticals Inc-Company Statement 13

Spectrum Pharmaceuticals Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 17

Section 2-Company Analysis 18

Company Overview 18

Spectrum Pharmaceuticals Inc-Business Description 19

R&D Overview 20

Spectrum Pharmaceuticals Inc-SWOT Analysis 21

SWOT Analysis-Overview 21

Spectrum Pharmaceuticals Inc-Strengths 21

Spectrum Pharmaceuticals Inc-Weaknesses 22

Spectrum Pharmaceuticals Inc-Opportunities 23

Spectrum Pharmaceuticals Inc-Threats 24

Spectrum Pharmaceuticals Inc-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Spectrum Pharmaceuticals Inc, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Sep 24, 2018: SPI Energy Co., Ltd. Exhibits its USolar Platform at Solar Power International 2018 36

Sep 24, 2018: SPI Energy Co., Ltd. Exhibits its USolar Platform at Solar Power International 2018 37

Aug 09, 2018: Spectrum Pharmaceuticals reports second quarter 2018 financial results and pipeline update 38

Aug 09, 2018: Spectrum Pharmaceuticals reports second quarter 2018 financial results and pipeline update 40

Aug 09, 2018: Spectrum Pharmaceuticals reports second quarter 2018 financial results and pipeline update 42

Aug 09, 2018: Spectrum Pharmaceuticals reports second quarter 2018 financial results and pipeline update 44

May 03, 2018: Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update 46

Apr 30, 2018: Spectrum Pharmaceuticals announces corporate governance enhancements and board changes 48

Apr 27, 2018: Company Profile for Spectrum Pharmaceuticals 49

Mar 07, 2018: Spectrum Pharmaceuticals to present corporate update at the Cowen and Company 38th annual health care conference on March 13th 50

Section 6-Appendix 51

Methodology 51

Ratio Definitions 51

About GlobalData 55

Contact Us 55

Disclaimer 55

List of Figures

Spectrum Pharmaceuticals Inc, Performance Chart (2013-2017) 30

Spectrum Pharmaceuticals Inc, Ratio Charts 32

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

List of Tables

Spectrum Pharmaceuticals Inc, Key Facts 6

Spectrum Pharmaceuticals Inc, Key Employees 7

Spectrum Pharmaceuticals Inc, Key Employee Biographies 8

Spectrum Pharmaceuticals Inc, Major Products and Services 9

Spectrum Pharmaceuticals Inc, History 10

Spectrum Pharmaceuticals Inc, Other Locations 16

Spectrum Pharmaceuticals Inc, Subsidiaries 16

Spectrum Pharmaceuticals Inc, Joint Venture 17

Spectrum Pharmaceuticals Inc, Key Competitors 25

Spectrum Pharmaceuticals Inc, Ratios based on current share price 26

Spectrum Pharmaceuticals Inc, Annual Ratios 27

Spectrum Pharmaceuticals Inc, Annual Ratios (Cont...1) 28

Spectrum Pharmaceuticals Inc, Annual Ratios (Cont...2) 29

Spectrum Pharmaceuticals Inc, Interim Ratios 31

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

Spectrum Pharmaceuticals Inc, Recent Deals Summary 35

Currency Codes 51

Capital Market Ratios 51

Equity Ratios 52

Profitability Ratios 52

Cost Ratios 53

Liquidity Ratios 53

Leverage Ratios 54

Efficiency Ratios 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sanofi S.A.

Pfizer Inc

Novartis Pharmaceuticals Corp

GlaxoSmithKline Plc

Genomic Health Inc

Endo International Plc

Eli Lilly and Co

Celgene Corp

Bristol-Myers Squibb Co

Biogen Inc

Bayer Corp

AstraZeneca Plc

Spectrum Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8578
Site License
USD 250 INR 17155
Corporate User License
USD 375 INR 25733

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com